Navigation Links
New conference tackles the tough questions in lung cancer

Lugano, Switzerland, 4th April 2008 Experts from around the world are gathering in Geneva next month at a new conference that aims to improve lung cancer treatment and answer unsolved questions about a disease that kills 1.5 million people each year.

The First European Lung Cancer Conference is an initiative of the International Association for the Study of Lung Cancer (IASLC) and the European Society for Medical Oncology (ESMO). It will be held from 23 to 26 April.

"The main objective of this meeting is to advance the quality of lung cancer treatment and find answers to unsolved problems which can contribute substantially to the improvement of patient survival," said Prof. Franoise Mornex, France, Scientific Co-Chair of the conference.

The meeting will include new scientific and clinical results from presented abstracts, as well as invited plenary speeches from top international experts.

Prof. Joseph Nevins from the Duke University Medical Center, US and Prof. David Beer from the University of Michigan, US will present new data showing how genetic signatures in early lung cancer can help doctors tailor treatments more effectively.

"The current methods for staging early lung cancer have limited success in predicting which patients will be cured and which will have cancer recurrence," says Prof. Rafael Rosell, Spain, the other Scientific Co-Chair of the conference. "This is a good example of one of the unsolved problems in lung cancer treatment we hope to address at this meeting."

Two significant controversy sessions will address new concepts in the treatment of both early and advanced lung cancer, announces Prof. Mornex: the use of alternative efficient treatments such as radiofrequency and radiation versus surgery in early lung cancer, and the role of surgery as a standard treatment for stage III non-small-cell lung cancer.

Other highlights of the conference will include a report about a new, highly accurate diagnostic test for lung squamous cell carcinoma, studies probing the role human viruses play in lung cancers, positive results from a trial of immunotherapy to treat lung cancer, and efficacy and safety results from an interim analysis of a phase III trial on stage IIIB-IV nonsmall-cell lung cancer.

"The conference will also feature workshops on molecular biology and targeted therapies that embody part of the future of lung cancer treatment," said Prof. Rosell.

"We hope that the work presented at the conference in these areas will contribute to great advances for many lung cancer patients."


Contact: Vanessa Pavinato
European Society for Medical Oncology

Related medicine news :

1. SXC Health Solutions to Present at the Suntrust 37th Annual Institutional Conference
2. Covance Inc. Invites You to Join the Webcast of Its First Quarter 2008 Financial Results Conference Call
3. Ventas to Present at Credit Suisse 2008 Global Real Estate Conference
4. Lilly Adjusts Time of Conference Call for First Quarter 2008 Financial Results Announcement
5. Hospice Community to Focus on Advocacy at National Leadership Conference
6. Zimmer Holdings Announces Live Audio Webcast and Conference Call of First Quarter 2008 Results
7. Running Pioneer Kathrine Switzer Will Headline Women on the Move Conference August 13-15, 2008 in Spearfish, SD
8. Shannon Brownlee, Author of Overtreated, to Keynote at Defined Healths 8th Annual Therapeutic Insight Conference
9. Abbott Hosts Conference Call for First-Quarter Earnings
10. Latest Advances in Diabetes Research to be Presented in San Francisco, California at Worlds Largest Diabetes Conference, June 6-10, 2008
11. USAID Participates in White House Office of Faith-Based and Community Initiatives Conferences in Rwanda and Zambia
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... In an ongoing Clinical ... Center (RMC) in Chicago, IL, UV Angel is evaluating the efficacy of its product ... intensive care units (totaling 30 beds) from May 2014 through October 2015 at a ...
(Date:11/25/2015)... ... November 25, 2015 , ... In ... nation’s Periwinkle Pioneers, individuals and groups responsible for advancing care for pulmonary hypertension ... Pioneers, nominated by the public, will receive special recognition throughout 2016 as part ...
(Date:11/25/2015)... ... ... Many people know of the common symptoms of low thyroid hormone (also ... many people who find their cholesterol levels and weight are creeping up are more ... they don’t have any of the other symptoms. , Thyroid hormone plays a major ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... lower prices in an early celebration of the early holiday shopping season. Starting ... $29.95 each (normally $33.95 ea). Black Friday promotional pricing is in addition to ...
(Date:11/24/2015)... Mississauga, ON (PRWEB) , ... November 24, 2015 , ... ... Deborah Williams without a referral for dental implants at her Mississauga, ON ... qualified and experienced in the placement of dental implants. , Missing teeth can ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... LYON , Frankreich, November 25, 2015 ... hat heute bekanntgegeben, dass sie eine Lizenz für das ... Inserm, Poxel, CNRS, UCBL und ENS-Lyon innehaben, an Enyo ... 2009 von FUI AAP8 ins Leben gerufenen und von ... NATHEB-Programms wurde FXR als ein Behandlungsziel für HBV identifiziert, ...
(Date:11/24/2015)... Nov. 24, 2015  Natera, Inc. (Nasdaq: ... genetic testing and the analysis of circulating ... present at the 27 th  Annual Piper ... 2015 at 1:00 p.m. ET.  Matthew Rabinowitz, Ph.D., CEO of ... business activities and financial outlook. ...
(Date:11/24/2015)... , 24. November 2015 Avery ... Pacemaker Systems, ist erfreut, die Berufung von ... bekannt geben zu können. ... --> Foto - ... (Schweden). Von 1984-1986 war er Fellow des ...
Breaking Medicine Technology: